191 results on '"Zuin, Giovanna"'
Search Results
2. Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group
3. DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease
4. Correction to: One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
5. Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
6. Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry
7. Dietary habits in Italian children with inflammatory bowel disease: A case‐control multicenter study.
8. Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group
9. Prevalence and clinical features of chronic uveitis in pediatric inflammatory bowel diseases: A nationwide study
10. MR enterography grading of pediatric ileocolonic Crohn disease activity based on a single bowel segment
11. Risk Factors for the Development of Eating Disorders in Adolescents with Early-Onset Inflammatory Bowel Diseases.
12. Major Abdominal Surgery for Pediatric Crohn’s Disease in the Anti-TNF Era: 10-Year Analysis of Data From the IBD Registry of Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition
13. Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition
14. Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group
15. Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
16. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide
17. Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.
18. Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report.
19. Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease
20. One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
21. Colonic inflammation in pediatric inflammatory bowel disease: detection with magnetic resonance enterography
22. Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn’s Disease: Determinants of Higher Adherence and Response
23. Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort
24. Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry
25. Additional file 6 of Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
26. Additional file 4 of Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
27. Additional file 2 of Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
28. Additional file 7 of Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
29. Additional file 1 of Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
30. Additional file 3 of Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
31. Additional file 5 of Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP)
32. Information for Pediatricians: A Need to be Satisfied?
33. Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group
34. Maternal Drug Use Is a Preeminent Risk Factor for Mother-to-Child Hepatitis C Virus Transmission: Results from a Multicenter Study of 1372 Mother-Infant Pairs
35. Introduction of Gluten, HLA Status, and the Risk of Celiac Disease in Children
36. COVID-19 in Immunosuppressed Children
37. Children With Inflammatory Bowel Disease in the COVID-19 Main Endemic Focus: The Lombardy Experience
38. Farmaci, sperimentazioni, registri, nei tempi dell’emergenza del coronavirus
39. Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac Disease
40. Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease: A Randomized Clinical Trial
41. Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
42. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy
43. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: Results from a multicenter study of 1372 mother-infant Pairs
44. Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
45. Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry
46. Orofacial granulomatosis in children: Think about Crohn's disease
47. Italian pediatric nutrition survey
48. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease
49. Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review
50. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.